tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders StocksMarket MoversTipRanks 50 IndexAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Trending StocksCompare StocksCompare ETFsTrump Dashboard
New
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Trending News
More News >
Education
Personal FinanceHow To Use TipRanksTipRanks LabsWebinar CenterGlossaryFAQs
About Us
About TipRanksContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News Wire
Follow Us
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Trump Dashboard
New
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Advertisement
Advertisement

LENZ Stock Latest News

Strong Buy Recommendation for LENZ Therapeutics: Early Approval and Strategic Launch of VIZZ Eye Drops
RatingsStrong Buy Recommendation for LENZ Therapeutics: Early Approval and Strategic Launch of VIZZ Eye Drops
19d ago
LENZ
Lenz Therapeutics price target raised to $53 from $44 at BofA
PremiumThe Fly
Lenz Therapeutics price target raised to $53 from $44 at BofA
21d ago
LENZ
Lenz Therapeutics price target raised to $56 from $48 at H.C. Wainwright
PremiumThe Fly
Lenz Therapeutics price target raised to $56 from $48 at H.C. Wainwright
23d ago
LENZ
Buy Rating for LENZ Therapeutics: Vizz’s Early FDA Approval and Market Differentiation Drive Growth Potential
PremiumRatings
Buy Rating for LENZ Therapeutics: Vizz’s Early FDA Approval and Market Differentiation Drive Growth Potential
23d ago
LENZ
Lenz Therapeutics price target raised to $52 from $49 at Citi
PremiumThe Fly
Lenz Therapeutics price target raised to $52 from $49 at Citi
23d ago
LENZ
LENZ Therapeutics Gains FDA Approval for VIZZ Eye Drop
PremiumCompany AnnouncementsLENZ Therapeutics Gains FDA Approval for VIZZ Eye Drop
24d ago
8K
LENZ
Lenz Therapeutics announces FDA approval of Vizz eye drop
Premium
The Fly
Lenz Therapeutics announces FDA approval of Vizz eye drop
24d ago
LENZ
LENZ Therapeutics trading resumes
Premium
The Fly
LENZ Therapeutics trading resumes
24d ago
LENZ
LENZ Therapeutics trading halted, news pending
PremiumThe Fly
LENZ Therapeutics trading halted, news pending
24d ago
LENZ
LENZ Therapeutics’ LNZ100 Eye Drop Gains Buy Rating Amid Positive KOL Feedback and Strategic Market Positioning
PremiumRatings
LENZ Therapeutics’ LNZ100 Eye Drop Gains Buy Rating Amid Positive KOL Feedback and Strategic Market Positioning
24d ago
LENZ
Lenz Therapeutics price target raised to $49 from $45 at Citi
PremiumThe Fly
Lenz Therapeutics price target raised to $49 from $45 at Citi
24d ago
LENZ
Lenz Therapeutics Prepares for LNZ100 Launch
PremiumCompany Announcements
Lenz Therapeutics Prepares for LNZ100 Launch
25d ago
LENZ
LENZ Therapeutics: Positioned for Growth with Strategic Global Expansion and Imminent FDA Approval
PremiumRatingsLENZ Therapeutics: Positioned for Growth with Strategic Global Expansion and Imminent FDA Approval
25d ago
LENZ
Lenz Therapeutics reports Q2 EPS (53c), consensus (54c)
Premium
The Fly
Lenz Therapeutics reports Q2 EPS (53c), consensus (54c)
25d ago
LENZ
Lenz announces CORXEL submitted NDA for LNZ100 in China
Premium
The Fly
Lenz announces CORXEL submitted NDA for LNZ100 in China
27d ago
LENZ
Lenz Therapeutics price target raised to $48 from $38 at H.C. Wainwright
PremiumThe Fly
Lenz Therapeutics price target raised to $48 from $38 at H.C. Wainwright
27d ago
LENZ
Lenz Therapeutics, Laboratoires Thea enter license, commercialization agreement
PremiumThe Fly
Lenz Therapeutics, Laboratoires Thea enter license, commercialization agreement
2M ago
LENZ
LENZ Therapeutics Holds 2025 Annual Stockholders Meeting
PremiumCompany Announcements
LENZ Therapeutics Holds 2025 Annual Stockholders Meeting
2M ago
8K
LENZ
LENZ Therapeutics Prepares for LNZ100 Launch
PremiumCompany Announcements
LENZ Therapeutics Prepares for LNZ100 Launch
3M ago
LENZ
Lenz Therapeutics’ Earnings Call Highlights Strong Outlook
PremiumCompany AnnouncementsLenz Therapeutics’ Earnings Call Highlights Strong Outlook
4M ago
LENZ
Lenz Therapeutics, Lotus enter license, commercialization agreement for LNZ100
Premium
The Fly
Lenz Therapeutics, Lotus enter license, commercialization agreement for LNZ100
4M ago
LENZ
LTUS
LENZ Therapeutics Positioned for Success with LNZ100 Ahead of 2025 PDUFA Date
Premium
Ratings
LENZ Therapeutics Positioned for Success with LNZ100 Ahead of 2025 PDUFA Date
4M ago
LENZ

Trending

Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >